JAK inhibitor Solcitinib, Purity ≥98%

Synonym: Solcitinib; 1206163-45-2; GLPG-0778; GLPG0778; GSK-2586184; GSK2586184A; GSK2586184; JAK inhibitor

MDL: MFCD26960569
CAS Number: 1206163-45-2
Compound CID: 44603362

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Solcitinib, soluble in DMSO and ethanol and insoluble in water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1.

Molecular Weight

389.45

Molecular Formula

C₂₂H₂₃N₅O₂

Targets

JAK1: 9.8 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 27 mg/mL (69.33 mM); Water: Insoluble; Ethanol: 3 mg/mL (7.7 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Solcitinib can be used to study the inhibition of JAK1 activity in research related to autoimmune diseases.